SBOT vs. QLI, MEIP, BFRG, UBX, LSTA, FBRX, JAGX, TXMD, CPIX, and HUGE
Should you be buying Stellar Biotechnologies stock or one of its competitors? The main competitors of Stellar Biotechnologies include Qilian International Holding Group (QLI), MEI Pharma (MEIP), Bullfrog AI (BFRG), Unity Biotechnology (UBX), Lisata Therapeutics (LSTA), Forte Biosciences (FBRX), Jaguar Health (JAGX), TherapeuticsMD (TXMD), Cumberland Pharmaceuticals (CPIX), and FSD Pharma (HUGE). These companies are all part of the "medical" sector.
Qilian International Holding Group (NASDAQ:QLI) and Stellar Biotechnologies (NASDAQ:SBOT) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, media sentiment, dividends, valuation, community ranking, analyst recommendations, risk and earnings.
1.7% of Stellar Biotechnologies shares are held by institutional investors. 58.7% of Qilian International Holding Group shares are held by company insiders. Comparatively, 7.8% of Stellar Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
In the previous week, Qilian International Holding Group had 2 more articles in the media than Stellar Biotechnologies. MarketBeat recorded 3 mentions for Qilian International Holding Group and 1 mentions for Stellar Biotechnologies. Qilian International Holding Group's average media sentiment score of 0.00 beat Stellar Biotechnologies' score of -0.15 indicating that Stellar Biotechnologies is being referred to more favorably in the news media.
Stellar Biotechnologies has lower revenue, but higher earnings than Qilian International Holding Group.
Qilian International Holding Group has a net margin of 0.00% compared to Qilian International Holding Group's net margin of -1,782.64%. Stellar Biotechnologies' return on equity of 0.00% beat Qilian International Holding Group's return on equity.
Stellar Biotechnologies received 233 more outperform votes than Qilian International Holding Group when rated by MarketBeat users. However, 100.00% of users gave Qilian International Holding Group an outperform vote while only 66.48% of users gave Stellar Biotechnologies an outperform vote.
Summary
Qilian International Holding Group beats Stellar Biotechnologies on 7 of the 11 factors compared between the two stocks.
Get Stellar Biotechnologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for SBOT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Stellar Biotechnologies Competitors List
Related Companies and Tools
